Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check7 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a small software update with no changes to content or visible features.SummaryDifference0.0%

- Check14 days agoChange DetectedThe glossary/MeSH term Fatty Liver Disease has been updated to Steatotic Liver Disease. This change aligns terminology with current classifications and affects indexing rather than the study data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a small software update applied to the page rendering.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This maintenance/versioning change does not modify the study content.SummaryDifference0.0%

- Check50 days agoChange DetectedA recruitment status line 'No longer looking for participants' was added, indicating the study is not actively enrolling. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the label for Intervention/Treatment was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment' along with a 'Revision: v3.6.0' tag.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a new build of the page rather than changes to study content.SummaryDifference0.0%

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.